Related Experiment Video

Updated: Feb 9, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

[Novel molecular targeting therapeutics for prostate cancer]

Hiroji Uemura¹, Noboru Nakaigawa, Hitoshi Ishiguro

¹Department of Urology, Yokohama City University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|February 18, 2005

Abstract:

Our previous study demonstrated that Angiotensin II (Ang-II) which is well known to be a main peptide of the renin-angiotensin system could activate the cell proliferation of prostate cancer as well as EGF, and an Ang-II receptor blocker(ARB) could inhibit it through the suppression of phosphorylation of MAPK and STAT3. Also, ARB exerted an antiproliferative effect on prostate cancer through paracrine factors from stromal cells. We believe that ARBs have the novel ability to suppress the development or progression of prostate cancer. Furthermore, based on the idea that inhibition of G protein-coupled receptor signaling in cancer and stromal cells could suppress prostate cancer growth, a novel treatment such as molecular targeting therapy to overcome this devastating disease could be possible in the future.

Insights

Angiotensin II (Ang-II) fuels prostate cancer growth, but Ang-II receptor blockers (ARBs) inhibit this by blocking key signaling pathways. ARBs show promise for suppressing prostate cancer development and progression.

Area of Science:

Endocrinology
Oncology
Molecular Biology

Context:

Prostate cancer cell proliferation is influenced by Angiotensin II (Ang-II), a key renin-angiotensin system peptide.
Epidermal Growth Factor (EGF) also promotes prostate cancer cell growth.
Ang-II receptor blockers (ARBs) have demonstrated an inhibitory effect on prostate cancer growth.

Purpose:

To investigate the antiproliferative effects of ARBs on prostate cancer.
To explore the molecular mechanisms by which ARBs inhibit prostate cancer, including MAPK and STAT3 phosphorylation.
To evaluate the role of stromal cell paracrine factors in ARB-mediated inhibition of prostate cancer.

Summary:

Previous research indicated Ang-II activates prostate cancer cell proliferation, similar to EGF.
ARBs inhibit prostate cancer growth by suppressing MAPK and STAT3 phosphorylation.
ARBs also exert antiproliferative effects via paracrine factors from stromal cells, suggesting a novel therapeutic approach.

Impact:

ARBs possess a novel ability to suppress prostate cancer development and progression.
Targeting G protein-coupled receptor signaling in cancer and stromal cells could lead to future molecular therapies for prostate cancer.
This research opens avenues for novel molecular targeting therapies against prostate cancer.

Read full analysis

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

Molecular Models

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.

Molecular Orbital Theory II

Molecular Orbital Theory II

Molecular Orbital Energy Diagrams

Molecular Orbital Theory I

Molecular Orbital Theory I

Overview of Molecular Orbital Theory

Predicting Molecular Geometry

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries

Articles linked to this work by shared authors, journal, and citation graph.

Symptom Bother Is Associated With Medical Care-Seeking for LUTS in Japanese Women: A Survey of 1800 Women.

Lower urinary tract symptoms·2026

Fewer Injections and Lower Drug Costs With Long-Acting GnRH Depot Formulations: A Nationwide Analysis of 2.3 Million Patient-Years in Japan.

Cancer reports (Hoboken, N.J.)·2026

Evaluation of the Collection Efficiency of a Wet-Type Electrostatic Precipitator for Aerosolized Influenza A Virus.

Microorganisms·2026

Procedure-specific temperature dependence and lag structure of urinary stone surgery: A nationwide open-data study in Japan, 2019-2024.

BJUI compass·2026

Two stress-responsive kinases suppress ferroptosis by activating antioxidant programs under mild oxidative stress.

Signal transduction and targeted therapy·2026

Primary Large Cell Neuroendocrine Carcinoma of the Bladder Successfully Treated With Radical Cystectomy Alone: A Case Report.

Clinical case reports·2026

See all related articles